CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance
Yu‐Chin Liu(Chang Gung University), Kwang‐Huei Lin(Chang Gung University of Science and Technology)
Cited by 19
Related Papers
FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis
|Developmental Cell|2019|109
Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway
|Cell Death and Disease|2016|46
Mitogen-Activated Protein Kinases Potentiate Thyroid Hormone Receptor Transcriptional Activity by Stabilizing Its Protein
|Endocrinology|2003|39
The long non-coding RNA LINC01013 enhances invasion of human anaplastic large-cell lymphoma
|Scientific Reports|2017|39
Novel function of GTPBP2 in promoting hepatocellular carcinoma progression through inhibition of BTRC-mediated KRAS degradation
|Cancer Cell International|2026|0